Pain in burned patients Injury, Occupational Diseases, Poisoning Pain in burned patients
Conditions
Interventions
Participants are randomly allocated to one of two groups: the intervention group or the control group.
Interventional drug: intravenous infusion of lidocaine starting with bolus dose 1 mg/kg, follow
Sponsors
Linkoping University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Burns more than 10 Total body surface area (tbsa) 2. Aged between 18 and 70 years 3. Adminstration of patient controlled anaglesia (morphine);Inclusion criteria: 1. Burns more than 10 Total body surface area (tbsa) 2. Aged between 18 and 70 years 3. Adminstration of patient controlled anaglesia (morphine)
Exclusion criteria
Exclusion criteria: 1. Untreated AV-block type II or III 2. Known heart failure 3. Known allergy to local anaesthesia 4. Liver cirrhosis and severe renal dysfunction ;Exclusion criteria: 1. Untreated AV-block type II or III 2. Known heart failure 3. Known allergy to local anaesthesia 4. Liver cirrhosis and severe renal dysfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Opioid consumption (intravenous and oral in milligram/day) is measured using the recordings from both infusion pump and nurses’ written doses administered at baseline day 0, days 1-3 and days 4-6.;Opioid consumption (intravenous and oral in milligram/day) is measured using the recordings from both infusion pump and nurses’ written doses administered at baseline day 0, days 1-3 and days 4-6. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain is measured using the visual analogue scale (measured six times per day) at baseline day 0, days 1-3 and days 4-6.;Pain is measured using the visual analogue scale (measured six times per day) at baseline day 0, days 1-3 and days 4-6. | — |
Countries
Sweden
Contacts
Public ContactFolke;Folke Sjoberg;Sjoberg
;
Outcome results
None listed